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Placental tumours are broadly divided into trophoblastic and non-trophoblastic tumours. The latter include 
chorioangiomas, teratomas, haemangiomas and 
haematomas. Placental chorioangiomas are benign 
vascular tumours and are the most common 
placental tumours with a prevalence of 1%.1 Large 
placental chorioangiomas are rare and may lead 
to pregnancy complications and poor perinatal 
outcomes, including fetal anaemia, hydrops fetalis, 
growth restriction, polyhydramnios and preterm 
delivery.1 We report a case of a large placental 
chorioangioma, the antenatal management and the 
maternal and fetal outcomes. 
Case Report
A 36-year-old gravida 5 healthy woman was 
diagnosed with a vascular placental tumour on 
ultrasound at 25 weeks of gestation. The tumour 
was 1 x 1 cm in size, with mixed echogenicity 
and well-defined margins. Until then, the patient 
had had an otherwise normal pregnancy with a 
negative serology for hepatitis and HIV and normal 
fetal anatomy scan. The woman had no significant 
past medical or surgical history. She had had two 
previous, full-term spontaneous vaginal deliveries 
and two spontaneous, first-trimester abortions. 
The initial scan evaluated in detail the placental 
function, characteristics of the tumour and the 
fetal anatomy. There were no fetal tumours or any 
other anomalies noted on that scan. Follow-up 
scans during pregnancy showed an increase in the 
tumour size, with it reaching a maximum of 6 x 5 
cm at 32 weeks of gestation. The tumour was within 
the centre of the umbilical cord insertion with a 
central feeding vessel [Figures 1 & 2]. 
A provisional diagnosis of chorioangioma was 
made and the patient was assessed weekly in the 
high-risk clinic for any signs of maternal or fetal 
complications. The woman was well throughout the 
pregnancy with no antenatal complications such 
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م�شاعفات احلمل و�شوء نتائج الفرتة املحيطة بالولدة. وت�شمل هذه امل�شاعفات فقر الدم اجلنيني، ا�شت�شقاء اجلنني، تقييد منو اجلنني، 
موه ال�شلى والولدة قبل الأوان. نعر�ص هنا تقرير حالة ورم وعائي م�شيمي كبري، واإدارة الرعاية ال�شابقة للولدة، ونتائج الأمومة واجلنني. 
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abstract: Placental tumours include placental chorioangiomas, teratomas, haemangiomas, and haematomas. 
Placental chorioangiomas are benign vascular tumours and are the most common placental tumours, with 
a prevalence of 1%. Large placental chorioangiomas are rare and may lead to pregnancy complications and 
poor perinatal outcomes. These complications include fetal anaemia, hydrops fetalis, fetal growth restriction, 
polyhydramnios, and preterm delivery. We report a case of a large placental chorioangioma, the antenatal 
management and the maternal and fetal outcomes. 
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as pregnancy-induced hypertension or gestational 
diabetes. The fetus was monitored closely and the 
mother was also asked to monitor its movements. 
Growth scans were performed every two weeks 
to exclude intrauterine growth restriction (IUGR), 
and a weekly biophysical profile, done by Doppler, 
included measurements of the middle cerebral 
artery peak systolic velocity (MCA-PSV). The 
cardiac function of the fetus was assessed and, 
fortunately, there were no signs of compromise 
such as cardiomegaly, abnormal ductus venosus 
(DV) waveforms, or signs of fetal hydrops. There 
was no evidence of polyhydramnios, IUGR or fetal 
anaemia on follow-up scans. At 37 weeks and 3 
days of gestation, the patient complained of reduced 
fetal movements; a scan showed a collapsed tumour 
4 x 3 cm in size with less vascularity and irregular 
margins. There were no changes in the Doppler 
measurement of MCA-PSV or in cardiac function.
Labour was induced and the patient had a 
spontaneous vaginal delivery of a healthy male baby 
of 2,730 g with Apgar scores of 9 and 10 at 1 and 
5 minutes, respectively. The postnatal assessment 
of the baby showed no evidence of anaemia or 
thrombocytopaenia. On macroscopic examination 
of the placenta, the umbilical cord was triple-
vesselled and unremarkable, and the extraplacental 
membranes were translucent. The placental disc 
was 19 cm x 16 cm x 4 cm with a trimmed weight 
of 666 g. Beneath the insertion of the umbilical 
cord, a 2 cm pale-brown intraparenchymal lesion 
was noted adjacent to which was a cystic space; 
together, these measured 4.5 cm across.
Histopathological examination of the pale 
area showed an infracted chorangioma formed 
of a network of dilated cavernous type vessels 
lined by CD-31 positive endothelial cells with 
intervening collagenous stroma [Figure 3]. The 
cystic space did not have a true lining and its wall 
was continuous with the chorionic plate. Placental 
villi were appropriate for gestational age and were 
unremarkable.
Discussion
Placental chorioangiomas are the most common 
placental tumours, with a prevalence of 1%. They 
are thought to be hamartomatous lesions rather 
than true neoplasms and should be differentiated 
from other placental tumours.1–3 Large placental 
chorioangiomas measuring more than 4 cm in size 
are rare, with an incidence of 1:500–1:16,000, and 
are associated with several perinatal complications 
including intrauterine fetal demise and premature 
birth.1–8 The main differential diagnoses include 
chorangiosis, chorangiomatosis and rare 
chorangiomas with trophoblastic proliferation.
This case of a large placental chorioangioma was 
followed very closely during the antenatal period. 
Fortunately, no complications occurred for either the 
mother or the fetus, except that the chorioangioma 
became infarcted at 37 weeks of gestation, requiring 
induction of labour. It is known that large tumours 
may produce degenerative phenomena like necrosis, 
calcifications, hyalinisation and infarction. The 
infarction usually occurs spontaneously, leading 
to a decrease in echogenicity, tumour volume and 
blood flow on colour Doppler images, as observed 
in this case.9
 
Figure 1: Placental chorioangioma of 6 x 5 cm in size 
within the centre of the umbilical cord with a feeding 
vessel.
 
Figure 2: Well-circumscribed lesion (arrow) within the 
placenta just beneath the insertion of the umbilical cord 
(asterisk). It had a pale tan cut surface. 
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The recurrence risk of chorangiomas is rare, but 
there are occasional reports of such cases, suggesting 
some environmental or genetic predisposition.10 
For example, there is a strong relationship between 
placental chorangiomas and gestation at high 
altitudes, suggesting the occurrence of vascular 
growth factors induced by hypoxia.11
Fetal growth restriction has been reported 
in association with large placental tumours.12 
The theory is not yet clear, but it could be due 
to these large vascular tumours acting as a 
physiological and functional dead space leading 
to placental insufficiency, chronic hypoxia, fetal 
compromise, fetal growth restriction and even 
death. Fetal anaemia could also result from these 
large tumours.13 Close monitoring with Doppler 
measurement of MCA-PSV, and looking for early 
signs of hyperdynamic circulation, are essential 
actions as fetal cardiomegaly is important during 
the antenatal period. Early detection could prevent 
subsequent major complications, such as fetal 
death by antenatal interventions like in utero fetal 
blood transfusion and early delivery at a reasonable 
gestational age. Our patient was followed very 
closely with weekly scans looking for early signs of 
fetal anaemia and biweekly growth scans to rule out 
fetal growth restriction.
A large series of 19 cases with giant placental 
chorioangiomas was reported recently. Of those, 
18 resulted in a variety of fetal complications, 
including fetal growth restriction in 6 cases and 
one with one stillbirth at 34 weeks’ gestation due 
to severe placental insufficiency and the mother's 
refusal of an early delivery.14 Polyhydramnios was 
reported in three cases, out of which two required 
amnioreduction.14 This series also included the 
antenatal interventions performed in fetuses with 
evidence of hyperdynamic circulation to prevent 
the development of hydrops fetalis. The intervention 
included fetoscopic laser treatment in one case, 
preterm delivery in one case, and interstitial 
laser therapy in three cases.14 Other possible 
interventions include fetoscopic devascularisation 
of the tumour by suture ligation of the arterial blood 
supply and alcohol ablation of the feeding vessel.15,16
Another group in Chile reported their 
experience with placental chorioangiomas, 
with 11 cases diagnosed over a 5-year period.17 
Polyhydramnios and preterm delivery were the 
most common complications. They concluded that 
amnioreduction in selected cases may improve the 
perinatal outcome; fetal hydrops carries the highest 
risk of perinatal death, and close follow-up of cases 
with no associated findings at the time of diagnosis 
is very important. 
Conclusion
Large placental chorioangioma are rare and may 
lead to adverse perinatal outcomes. Prenatal 
diagnosis of these tumours with close follow-up 
during the antenatal period and early intervention 
is crucial, and may result in a healthy mother and 
fetus. 
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